Jones C, Phillips E, Davis C, Arbuckle J, Yaqoob M, Burgess G M, Docherty R J, Webb M, Bevan S J, McIntyre P
Novartis Institute for Medical Sciences, London, UK.
Eur J Pharmacol. 1999 Jun 25;374(3):423-33. doi: 10.1016/s0014-2999(99)00315-5.
This report describes the characterisation of cloned rat and human bradykinin B1 receptors in African green monkey kidney fibroblast (Cos-7) cells. A ligand binding assay with [3H]des-Arg10-kallidin was used to compare their pharmacology with respect to known bradykinin B1 and B2 receptor ligands. In addition, the pharmacology of T-kinin and its' derivative des-Arg11-T-kinin was investigated. The cloned rat receptor had a similar pharmacology to that of the recently described mouse receptor and differs from that described for the human receptor. The rat receptor had a higher affinity for des-Arg11-T-kinin than the human receptor. These differences in pharmacological properties may relate to the presence of T-kinin, bradykinin and their des-Arg derivatives as the major physiological peptides in rat and the predominance of kallidin and its derivatives in human. We confirm that the rat bradykinin B1 receptor gene is organised in a two exon structure and differs from the human gene which has a three exon structure and we further examine the inducible expression of this gene in a wide range of tissues using Northern blotting.
本报告描述了非洲绿猴肾成纤维细胞(Cos-7细胞)中克隆的大鼠和人缓激肽B1受体的特性。使用[3H]去-Arg10-胰激肽进行配体结合试验,以比较它们与已知缓激肽B1和B2受体配体相关的药理学特性。此外,还研究了T-激肽及其衍生物去-Arg11-T-激肽的药理学特性。克隆的大鼠受体具有与最近描述的小鼠受体相似的药理学特性,与人受体的药理学特性不同。大鼠受体对去-Arg11-T-激肽的亲和力高于人受体。这些药理学特性的差异可能与大鼠中T-激肽、缓激肽及其去-Arg衍生物作为主要生理肽的存在以及人中印-10-激肽及其衍生物的优势有关。我们证实大鼠缓激肽B1受体基因由两个外显子结构组成,与人基因不同,人基因具有三个外显子结构,并且我们使用Northern印迹法进一步研究了该基因在多种组织中的诱导表达。